ROYAL BANK OF CANADA - ANTHERA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$2,0000.0%6,594
+136.3%
0.00%
Q4 2016$2,0000.0%2,791
+203.4%
0.00%
Q3 2016$2,000
-66.7%
920
-48.6%
0.00%
Q2 2016$6,000
+50.0%
1,790
+79.0%
0.00%
Q1 2016$4,000
-20.0%
1,000
-8.9%
0.00%
Q4 2015$5,000
-72.2%
1,098
-62.8%
0.00%
Q3 2015$18,000
-35.7%
2,954
-7.7%
0.00%
Q2 2015$28,0003,200
+45614.3%
0.00%
Q1 2014$07
+40.0%
0.00%
Q3 2013$050.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,431,196$2,748,0001.18%
Abingworth LLP 437,994$832,0000.50%
Broadfin Capital, LLC 1,301,622$2,499,0000.26%
Rhenman & Partners Asset Management AB 400,000$768,0000.22%
BVF INC/IL 559,624$1,074,0000.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,691,857$3,248,0000.12%
Perceptive Advisors 478,456$919,0000.10%
Gruss Capital Management LP 1,720,000$3,302,0000.08%
SECTORAL ASSET MANAGEMENT INC 247,961$476,0000.02%
Spark Investment Management LLC 36,400$69,0000.01%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders